DMAC
Price
$3.67
Change
-$0.29 (-7.32%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
169.71M
47 days until earnings call
WHWK
Price
$1.68
Change
-$0.02 (-1.18%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
79.53M
34 days until earnings call
Ad is loading...

DMAC vs WHWK

Header iconDMAC vs WHWK Comparison
Open Charts DMAC vs WHWKBanner chart's image
DiaMedica Therapeutics
Price$3.67
Change-$0.29 (-7.32%)
Volume$1.21K
Capitalization169.71M
Whitehawk Therapeutics
Price$1.68
Change-$0.02 (-1.18%)
Volume$965
Capitalization79.53M
DMAC vs WHWK Comparison Chart
Loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DMAC vs. WHWK commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a Hold and WHWK is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DMAC: $3.96 vs. WHWK: $1.70)
Brand notoriety: DMAC and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 149% vs. WHWK: 30%
Market capitalization -- DMAC: $157.71M vs. WHWK: $78.6M
DMAC [@Biotechnology] is valued at $157.71M. WHWK’s [@Biotechnology] market capitalization is $78.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than DMAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 4 TA indicator(s) are bullish while WHWK’s TA Score has 4 bullish TA indicator(s).

  • DMAC’s TA Score: 4 bullish, 5 bearish.
  • WHWK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, WHWK is a better buy in the short-term than DMAC.

Price Growth

DMAC (@Biotechnology) experienced а -2.94% price change this week, while WHWK (@Biotechnology) price change was -11.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

DMAC is expected to report earnings on May 20, 2025.

WHWK is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMAC($170M) has a higher market cap than WHWK($79.5M). DMAC YTD gains are higher at: -27.072 vs. WHWK (-46.117).
DMACWHWKDMAC / WHWK
Capitalization170M79.5M214%
EBITDA-24.07MN/A-
Gain YTD-27.072-46.11759%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash50.2MN/A-
Total Debt365KN/A-
FUNDAMENTALS RATINGS
DMAC vs WHWK: Fundamental Ratings
DMAC
WHWK
OUTLOOK RATING
1..100
5456
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
9894
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6591
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
4550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (34) in the Pharmaceuticals Major industry is in the same range as DMAC (64) in the Biotechnology industry. This means that WHWK’s stock grew similarly to DMAC’s over the last 12 months.

WHWK's Profit vs Risk Rating (94) in the Pharmaceuticals Major industry is in the same range as DMAC (98) in the Biotechnology industry. This means that WHWK’s stock grew similarly to DMAC’s over the last 12 months.

DMAC's SMR Rating (97) in the Biotechnology industry is in the same range as WHWK (98) in the Pharmaceuticals Major industry. This means that DMAC’s stock grew similarly to WHWK’s over the last 12 months.

DMAC's Price Growth Rating (65) in the Biotechnology industry is in the same range as WHWK (91) in the Pharmaceuticals Major industry. This means that DMAC’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's P/E Growth Rating (95) in the Pharmaceuticals Major industry is in the same range as DMAC (100) in the Biotechnology industry. This means that WHWK’s stock grew similarly to DMAC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DMACWHWK
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGLO0.400.09
+29.00%
theglobe.com, inc.
OMRNY28.410.48
+1.70%
OMRON Corp.
CTTAY7.020.02
+0.35%
Continental AG
DANOY15.240.01
+0.07%
Danone
ASYS4.80-0.01
-0.21%
Amtech Systems

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
N/A
AXON - WHWK
44%
Loosely correlated
+3.18%
DMAC - WHWK
42%
Loosely correlated
+5.60%
GOSS - WHWK
41%
Loosely correlated
-1.59%
AMRN - WHWK
37%
Loosely correlated
-2.26%
BEAM - WHWK
37%
Loosely correlated
+4.79%
More